If 340B is helping patients, why are hospitals fighting transparency?

The Trump administration is mulling a pilot program to introduce transparency into the 340B drug discount program, which aims to assist hospitals serving low-income patients by securing lower medication costs. Despite the program's intent to benefit vulnerable populations, many hospitals are resisting these transparency measures. This opposition raises questions about whether the real goal is to obscure how the discounts are utilized, potentially undermining the program's core mission. The push for transparency could reveal whether hospitals are genuinely benefiting patients or diverting funds for other purposes.